Intravenous Anesthesia Market Growth, Analysis, and Forecast by 2031

Coverage: Intravenous Anesthesia Market covers analysis By Product (Tetrazolium, Ketamine, Sodium Oxybate, Others); End User (Hospitals, Clinics, Others), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00020519
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

The Intravenous Anesthesia Market is expected to register a CAGR of 3.45% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.

The report is segmented by Product (Tetrazolium, Ketamine, Sodium Oxybate, Others); and End User (Hospitals, Clinics, Others). The global analysis is broken down at the regional level and for major countries. The market evaluation is presented in US$ for the above segmental analysis.

Purpose of the Report

The report Intravenous Anesthesia Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:

  • Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
  • Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
  • Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.

Intravenous Anesthesia Market Segmentation

Product
  • Tetrazolium
  • Ketamine
  • Sodium Oxybate
End User
  • Hospitals
  • Clinics

Strategic Insights

Intravenous Anesthesia Market Growth Drivers
  • Rising Demand for Outpatient Surgeries: The increasing demand for outpatient surgeries significantly drives the growth of the intravenous anesthesia market. Outpatient surgeries, also known as same-day discharge procedures, are becoming more common due to advancements in minimally invasive techniques, which allow for shorter recovery times and fewer complications. Intravenous anesthesia is a preferred method for these surgeries because of its quicker onset, more controlled sedation, and faster recovery compared to inhalational anesthesia. These procedures, including cataract surgeries, joint replacements, and gastrointestinal surgeries, require anesthesia that can quickly induce and reverse sedation, making intravenous anesthesia ideal. The rise in outpatient procedures is being driven by the growing preference for less invasive treatments, cost-effectiveness, and patient convenience. As hospitals and surgical centers increasingly offer outpatient services, the demand for intravenous anesthesia drugs and equipment continues to grow, contributing to the market’s expansion. The convenience of receiving anesthesia through intravenous methods further supports this growth driver, as it enables patients to return home the same day, reducing overall healthcare costs. Therefore, outpatient surgeries, with intravenous anesthesia as a cornerstone of safe and efficient anesthesia administration, serve as a strong growth driver for the market.
  • Technological Advancements in Anesthesia Delivery Systems: Advancements in anesthesia delivery systems are a major driver for the intravenous anesthesia market. The development of automated anesthesia delivery machines and computer-controlled pumps has made the administration of intravenous anesthesia more precise and reliable. These devices allow anesthesiologists to control the dose of anesthetics with greater accuracy, ensuring that patients are sedated at the appropriate level and reducing the risks associated with anesthesia administration. Additionally, advancements in real-time monitoring systems provide anesthesiologists with continuous feedback on patient vitals, enabling them to make more informed decisions about anesthesia levels. The integration of artificial intelligence (AI) and machine learning technologies into anesthesia systems is further enhancing the safety and efficiency of intravenous anesthesia. AI-driven systems can analyze patient data to predict the optimal amount of anesthesia needed for different patients based on individual characteristics such as age, weight, and medical history. As these technologies continue to evolve, intravenous anesthesia will become even safer and more effective, providing greater control for medical professionals and improving patient outcomes. These innovations, along with the growing focus on patient safety, are fueling the demand for intravenous anesthesia systems, making technological advancements a key driver of market growth.
  • Increasing Prevalence of Chronic Diseases and Surgical Procedures: The rising prevalence of chronic diseases, such as cardiovascular disorders, diabetes, and musculoskeletal conditions, significantly contributes to the growth of the intravenous anesthesia market. These diseases often require surgical interventions for management, including procedures like bypass surgeries, joint replacements, and other major surgeries. Intravenous anesthesia plays a critical role in these surgeries, providing effective sedation with controlled and quick recovery times. As the global population continues to age and the incidence of chronic diseases increases, more patients will require surgical treatments, leading to a rise in the need for anesthesia services. For example, elderly patients often require complex surgeries for conditions like osteoarthritis or heart disease, and intravenous anesthesia is an ideal choice for these patients due to its ability to be carefully adjusted to accommodate their specific needs. Furthermore, the growing prevalence of obesity and related comorbidities is increasing the need for surgeries, further fueling the demand for intravenous anesthesia. As healthcare systems address the needs of chronic disease patients, intravenous anesthesia is becoming an integral part of the surgical treatment process, driving continued growth in the market.
Intravenous Anesthesia Market Future Trends
  • Rise of Personalized Anesthesia Solutions: A prominent future trend in the intravenous anesthesia market is the increasing shift toward personalized anesthesia solutions. As healthcare providers focus more on tailoring treatments to individual patients, anesthesia administration is also becoming more customized. Personalized anesthesia involves adjusting the type, dosage, and delivery method of anesthesia based on a patient’s unique medical history, genetics, and other individual factors. Advances in pharmacogenomics, which studies how genetics affect drug responses, are allowing anesthesiologists to predict the best anesthesia options for specific patients. This trend is expected to enhance the safety and effectiveness of intravenous anesthesia, as it ensures that each patient receives an optimal and individualized anesthetic plan. Personalized anesthesia solutions can minimize adverse reactions and improve recovery times, making the anesthesia process more efficient and patient-friendly. With an increased focus on precision medicine, the demand for customized anesthesia services, including intravenous anesthesia, will grow. This trend is expected to have a long-lasting impact on the intravenous anesthesia market as healthcare systems worldwide move toward more patient-centric approaches to treatment.
  • Integration of Artificial Intelligence in Anesthesia Monitoring: The integration of artificial intelligence (AI) in anesthesia monitoring is poised to be a game-changing trend in the intravenous anesthesia market. AI-powered systems are increasingly being used to monitor patients’ vitals and anesthesia levels in real-time, providing anesthesiologists with valuable insights and recommendations for adjustments. These systems analyze large amounts of patient data, including heart rate, blood pressure, oxygen saturation, and respiratory rate, to ensure that anesthesia is administered at the optimal levels. The integration of AI helps prevent human error, ensures greater accuracy in anesthesia administration, and enhances patient safety. In addition to monitoring, AI is being used to predict anesthesia outcomes, making it easier for anesthesiologists to anticipate complications and take preventive measures. As AI continues to advance, its role in intravenous anesthesia administration will likely expand, making the process more efficient, precise, and safer for patients. The growing adoption of AI in healthcare and anesthesia is expected to drive the future growth of the intravenous anesthesia market, with AI technologies revolutionizing how anesthesia is monitored and delivered.
  • Growth of Day Surgery Centers: The increasing popularity of day surgery centers is another key trend shaping the intravenous anesthesia market. Day surgery centers, which specialize in same-day discharge procedures, are becoming more common due to their cost-effectiveness, convenience, and faster recovery times. These centers often perform procedures like cosmetic surgeries, minor orthopedic surgeries, and diagnostic procedures that require anesthesia. As the demand for outpatient and same-day discharge procedures rises, intravenous anesthesia is becoming the preferred choice due to its ability to quickly induce and reverse sedation. The trend toward day surgery centers is also supported by advancements in surgical technology and anesthesia techniques, which allow patients to recover more rapidly and return home on the same day. The growth of these centers is expected to increase the demand for intravenous anesthesia, as they focus on providing high-quality, safe, and efficient anesthesia solutions for patients undergoing outpatient procedures. As more healthcare facilities adopt this model, intravenous anesthesia will continue to play a crucial role in ensuring the success of day surgeries.
Intravenous Anesthesia Market Opportunities
  • Growth in Geriatric Population Requiring Anesthesia Services: The global increase in the geriatric population presents a significant growth opportunity for the intravenous anesthesia market. Older adults typically require a higher volume of medical procedures, including surgeries for age-related conditions such as cataracts, joint replacements, and cardiovascular issues. Anesthesia requirements for geriatric patients are different from those of younger individuals, and intravenous anesthesia offers several advantages, including precise control over sedation levels and a faster recovery time. As the geriatric population continues to rise due to increased life expectancy, there will be a growing demand for anesthesia services that cater to this age group. The elderly often have multiple comorbidities that necessitate careful monitoring during anesthesia, and intravenous anesthesia, which can be adjusted more easily than inhalational anesthesia, provides greater safety and effectiveness. Furthermore, many geriatric patients may undergo outpatient procedures, making intravenous anesthesia an ideal choice for short-duration surgeries. Healthcare systems worldwide are recognizing the need to tailor anesthetic approaches to the aging population, creating a strong demand for intravenous anesthesia products that can accommodate the specific needs of elderly patients. As the aging population increases, the intravenous anesthesia market is expected to expand, with a greater focus on products designed for geriatric care, ultimately contributing to market growth.
  • Increasing Demand for Minimally Invasive Surgeries: The increasing preference for minimally invasive surgeries presents a significant growth opportunity for the intravenous anesthesia market. As healthcare technology advances, there has been a growing trend toward procedures that require smaller incisions, faster recovery times, and less postoperative discomfort. Intravenous (IV) anesthesia is commonly used in these types of surgeries due to its ability to provide fast, controlled sedation and deeper anesthesia when necessary. The demand for minimally invasive procedures, such as laparoscopic surgeries, endoscopic procedures, and robotic-assisted surgeries, is rising due to their benefits, including shorter recovery periods and reduced risk of infection. Since intravenous anesthesia allows for quicker onset and recovery, it is a preferred choice for many of these procedures. Additionally, as patient awareness about the advantages of minimally invasive surgeries grows, more individuals are opting for these procedures, further increasing the demand for intravenous anesthesia. The growing trend toward outpatient surgeries also contributes to the rise in intravenous anesthesia usage, as these procedures typically require shorter anesthesia durations. Therefore, as minimally invasive surgery adoption continues to increase, the intravenous anesthesia market is expected to experience substantial growth.
  • Technological Advancements in Intravenous Anesthesia Delivery Systems: Technological advancements in intravenous anesthesia delivery systems present significant growth opportunities in the market. Innovations in anesthesia technology have led to the development of more efficient, safer, and user-friendly delivery systems. For example, the introduction of automated drug infusion pumps and computer-controlled anesthesia machines has improved the precision and control of intravenous anesthesia administration. These systems allow anesthesiologists to administer the correct dosage with greater accuracy and minimize the risk of human error. The development of real-time monitoring systems that track patient vitals and anesthesia depth also contributes to enhanced patient safety during procedures. Additionally, the integration of artificial intelligence (AI) and machine learning in anesthesia systems offers the potential for more personalized and optimized anesthesia care. As healthcare facilities adopt more advanced technology, there will be an increasing demand for intravenous anesthesia drugs and delivery systems. These advancements also allow for a smoother and more comfortable patient experience, leading to higher adoption rates in both surgical and outpatient settings. As the technology continues to evolve, the intravenous anesthesia market will see increased demand for next-generation products that offer better control, improved safety profiles, and enhanced efficiency, providing opportunities for both established and emerging players to capitalize on these innovations.

Market Report Scope

Key Selling Points

  • Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Intravenous Anesthesia Market, providing a holistic landscape.
  • Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
  • Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
  • Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.

The research report on the Intravenous Anesthesia Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.

REGIONAL FRAMEWORK
World Geography

Have a question?

Analyst

Mrinal

Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst   Speak to Analyst
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
MARKET PLAYERS
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the expected CAGR of the Intravenous Anesthesia Market?

The Intravenous Anesthesia Market is estimated to witness a CAGR of 3.45% from 2025 to 2031.

What are the driving factors impacting the Intravenous Anesthesia Market?

The major factors driving the Intravenous Anesthesia Market are Rising Demand for Outpatient Surgeries, Technological Advancements in Anesthesia Delivery Systems, and Increasing Prevalence of Chronic Diseases and Surgical Procedures.

What are the future trends of the Intravenous Anesthesia Market?

Future trends in the Intravenous Anesthesia Market are Rise of Personalized Anesthesia Solutions, Integration of Artificial Intelligence in Anesthesia Monitoring, Growth of Day Surgery Centers.

Which are the leading players in the Intravenous Anesthesia Market?

Some of the players operating in the market are AstraZeneca,  Fresenius Kabi, Baxter International, Braun, Maruishi, Piramal Healthcare, Hikma Pharmaceuticals PLC, Mylan, Nhwa, Lunan

What are the deliverable formats of the Intravenous Anesthesia Market report?

The report can be delivered in PDF/PPT format; we can also share an excel datasheet based on the request.

What are the options available for the customization of this report?

Some customization options available based on the request are an additional 3–5 company profiles and a country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation# as our team would review the same and check the feasibility.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Intravenous Anesthetic Market - By Product
1.3.2 Intravenous Anesthetic Market - By End User
1.3.3 Intravenous Anesthetic Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. INTRAVENOUS ANESTHETIC MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. INTRAVENOUS ANESTHETIC MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. INTRAVENOUS ANESTHETIC MARKET - GLOBAL MARKET ANALYSIS
6.1. INTRAVENOUS ANESTHETIC - GLOBAL MARKET OVERVIEW
6.2. INTRAVENOUS ANESTHETIC - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. INTRAVENOUS ANESTHETIC MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. TETRAZOLIUM
7.3.1. Overview
7.3.2. Tetrazolium Market Forecast and Analysis
7.4. KETAMINE
7.4.1. Overview
7.4.2. Ketamine Market Forecast and Analysis
7.5. SODIUM OXYBATE
7.5.1. Overview
7.5.2. Sodium Oxybate Market Forecast and Analysis
8. INTRAVENOUS ANESTHETIC MARKET - REVENUE AND FORECASTS TO 2028 - END USER
8.1. OVERVIEW
8.2. END USER MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. CLINICS
8.4.1. Overview
8.4.2. Clinics Market Forecast and Analysis
8.5. OTHER
8.5.1. Overview
8.5.2. Other Market Forecast and Analysis
9. INTRAVENOUS ANESTHETIC MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Intravenous Anesthetic Market Overview
9.1.2 North America Intravenous Anesthetic Market Forecasts and Analysis
9.1.3 North America Intravenous Anesthetic Market Forecasts and Analysis - By Product
9.1.4 North America Intravenous Anesthetic Market Forecasts and Analysis - By End User
9.1.5 North America Intravenous Anesthetic Market Forecasts and Analysis - By Countries
9.1.5.1 United States Intravenous Anesthetic Market
9.1.5.1.1 United States Intravenous Anesthetic Market by Product
9.1.5.1.2 United States Intravenous Anesthetic Market by End User
9.1.5.2 Canada Intravenous Anesthetic Market
9.1.5.2.1 Canada Intravenous Anesthetic Market by Product
9.1.5.2.2 Canada Intravenous Anesthetic Market by End User
9.1.5.3 Mexico Intravenous Anesthetic Market
9.1.5.3.1 Mexico Intravenous Anesthetic Market by Product
9.1.5.3.2 Mexico Intravenous Anesthetic Market by End User
9.2. EUROPE
9.2.1 Europe Intravenous Anesthetic Market Overview
9.2.2 Europe Intravenous Anesthetic Market Forecasts and Analysis
9.2.3 Europe Intravenous Anesthetic Market Forecasts and Analysis - By Product
9.2.4 Europe Intravenous Anesthetic Market Forecasts and Analysis - By End User
9.2.5 Europe Intravenous Anesthetic Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Intravenous Anesthetic Market
9.2.5.1.1 Germany Intravenous Anesthetic Market by Product
9.2.5.1.2 Germany Intravenous Anesthetic Market by End User
9.2.5.2 France Intravenous Anesthetic Market
9.2.5.2.1 France Intravenous Anesthetic Market by Product
9.2.5.2.2 France Intravenous Anesthetic Market by End User
9.2.5.3 Italy Intravenous Anesthetic Market
9.2.5.3.1 Italy Intravenous Anesthetic Market by Product
9.2.5.3.2 Italy Intravenous Anesthetic Market by End User
9.2.5.4 Spain Intravenous Anesthetic Market
9.2.5.4.1 Spain Intravenous Anesthetic Market by Product
9.2.5.4.2 Spain Intravenous Anesthetic Market by End User
9.2.5.5 United Kingdom Intravenous Anesthetic Market
9.2.5.5.1 United Kingdom Intravenous Anesthetic Market by Product
9.2.5.5.2 United Kingdom Intravenous Anesthetic Market by End User
9.2.5.6 Rest of Europe Intravenous Anesthetic Market
9.2.5.6.1 Rest of Europe Intravenous Anesthetic Market by Product
9.2.5.6.2 Rest of Europe Intravenous Anesthetic Market by End User
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Intravenous Anesthetic Market Overview
9.3.2 Asia-Pacific Intravenous Anesthetic Market Forecasts and Analysis
9.3.3 Asia-Pacific Intravenous Anesthetic Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Intravenous Anesthetic Market Forecasts and Analysis - By End User
9.3.5 Asia-Pacific Intravenous Anesthetic Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Intravenous Anesthetic Market
9.3.5.1.1 Australia Intravenous Anesthetic Market by Product
9.3.5.1.2 Australia Intravenous Anesthetic Market by End User
9.3.5.2 China Intravenous Anesthetic Market
9.3.5.2.1 China Intravenous Anesthetic Market by Product
9.3.5.2.2 China Intravenous Anesthetic Market by End User
9.3.5.3 India Intravenous Anesthetic Market
9.3.5.3.1 India Intravenous Anesthetic Market by Product
9.3.5.3.2 India Intravenous Anesthetic Market by End User
9.3.5.4 Japan Intravenous Anesthetic Market
9.3.5.4.1 Japan Intravenous Anesthetic Market by Product
9.3.5.4.2 Japan Intravenous Anesthetic Market by End User
9.3.5.5 South Korea Intravenous Anesthetic Market
9.3.5.5.1 South Korea Intravenous Anesthetic Market by Product
9.3.5.5.2 South Korea Intravenous Anesthetic Market by End User
9.3.5.6 Rest of Asia Pacific Intravenous Anesthetic Market
9.3.5.6.1 Rest of Asia Pacific Intravenous Anesthetic Market by Product
9.3.5.6.2 Rest of Asia Pacific Intravenous Anesthetic Market by End User
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Intravenous Anesthetic Market Overview
9.4.2 Middle East and Africa Intravenous Anesthetic Market Forecasts and Analysis
9.4.3 Middle East and Africa Intravenous Anesthetic Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Intravenous Anesthetic Market Forecasts and Analysis - By End User
9.4.5 Middle East and Africa Intravenous Anesthetic Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Intravenous Anesthetic Market
9.4.5.1.1 South Africa Intravenous Anesthetic Market by Product
9.4.5.1.2 South Africa Intravenous Anesthetic Market by End User
9.4.5.2 Saudi Arabia Intravenous Anesthetic Market
9.4.5.2.1 Saudi Arabia Intravenous Anesthetic Market by Product
9.4.5.2.2 Saudi Arabia Intravenous Anesthetic Market by End User
9.4.5.3 U.A.E Intravenous Anesthetic Market
9.4.5.3.1 U.A.E Intravenous Anesthetic Market by Product
9.4.5.3.2 U.A.E Intravenous Anesthetic Market by End User
9.4.5.4 Rest of Middle East and Africa Intravenous Anesthetic Market
9.4.5.4.1 Rest of Middle East and Africa Intravenous Anesthetic Market by Product
9.4.5.4.2 Rest of Middle East and Africa Intravenous Anesthetic Market by End User
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Intravenous Anesthetic Market Overview
9.5.2 South and Central America Intravenous Anesthetic Market Forecasts and Analysis
9.5.3 South and Central America Intravenous Anesthetic Market Forecasts and Analysis - By Product
9.5.4 South and Central America Intravenous Anesthetic Market Forecasts and Analysis - By End User
9.5.5 South and Central America Intravenous Anesthetic Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Intravenous Anesthetic Market
9.5.5.1.1 Brazil Intravenous Anesthetic Market by Product
9.5.5.1.2 Brazil Intravenous Anesthetic Market by End User
9.5.5.2 Argentina Intravenous Anesthetic Market
9.5.5.2.1 Argentina Intravenous Anesthetic Market by Product
9.5.5.2.2 Argentina Intravenous Anesthetic Market by End User
9.5.5.3 Rest of South and Central America Intravenous Anesthetic Market
9.5.5.3.1 Rest of South and Central America Intravenous Anesthetic Market by Product
9.5.5.3.2 Rest of South and Central America Intravenous Anesthetic Market by End User
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL INTRAVENOUS ANESTHETIC MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. INTRAVENOUS ANESTHETIC MARKET, KEY COMPANY PROFILES
12.1. ASTRAZENECA
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. FRESENIUS KABI
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BAXTER INTERNATIONAL
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BRAUN
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MARUISHI
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. PIRAMAL HEALTHCARE
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. HIKMA PHARMACEUTICALS PLC
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. MYLAN
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. NHWA
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. LUNAN
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. AstraZeneca
2. Fresenius Kabi
3. Baxter International
4. Braun
5. Maruishi
6. Piramal Healthcare
7. Hikma Pharmaceuticals PLC
8. Mylan
9. Nhwa
10. Lunan
11. Abbott Laboratories
12. Hospira
13. F. Hoffmann-La Roche AG
14. B. Braun Melsungen AG
15. Eisai Co. Ltd

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..